A growing number of companies ranging from gyms to meal delivery services are launching new offerings to capitalize on a known issue that can happen for patients on weight loss drugs such as Ozempic and Wegovy, The New York Times…
Ohio's Board of Pharmacy handed a CVS pharmacy a $250,000 fine and probation for at least three years following a 2021 investigation that found understaffing, a broken air conditioning unit, unsafe storage for medications and other issues.
If the FDA removes the approval of phenylephrine, a common ingredient used in decongestants that research shows is ineffective, a new study says supply chain disruptions are likely.
A day after CVS Health reported earning $2 billion in its fourth quarter of 2023, the Pharmacy Guild — an aspiring union of retail pharmacists — criticized the company, saying CVS' profits are from "chronic understaffing."
In a Feb. 5 meeting with retail pharmacy CEOs, HHS Secretary Xavier Becerra stressed that patients should not be paying the full list price or high copays for Pfizer's Paxlovid drug.
Patients who take Ozempic, Mounjaro and Wegovy are less likely to be diagnosed with anxiety or depression compared to those who don't receive the popular diabetes and weight loss drugs, according to a new study.
Cincinnati-based Mercy Health is moving its Urbana (Ohio) Hospital's pharmacy from a small hallway space near the emergency department to its own space in 2024.
Drug shortages inflict more than $550 million in additional costs every year on hospitals and health systems, the American Hospital Association said in a letter to Congress.
Last fall, FDA inspectors found multiple safety and quality issues at one of the manufacturing sites Novo Nordisk has agreed to purchase, according to a Feb. 6 Bloomberg report.
